-transparent.png){kind=logo}
Pancreatic islet transplantation is a rapidly evolving field. It has been increasingly regarded as a promising approach for the correction of dysglycemia associated with type 1 diabetes mellitus (allogenic islet transplantation), or the prevention of surgical diabetes in chronic pancreatitis subjects undergoing total pancreatectomy (autologous islet transplantation). In this review, we discuss the latest literature pertaining to metabolic outcomes of autologous and allogenic islet transplantation, shedding close light on our own latest experience in the autologous islet transplantation setting.
| UI | MeSH Term | Description | Entries |
|---|
Related Publications
Khawla F Ali, and
Betul Hatipoglu
September 2009,
Transplantation,
Khawla F Ali, and
Betul Hatipoglu
October 2017,
Current opinion in organ transplantation,
Khawla F Ali, and
Betul Hatipoglu
January 1990,
Langenbecks Archiv fur Chirurgie,
Khawla F Ali, and
Betul Hatipoglu
April 1978,
The Surgical clinics of North America,
Khawla F Ali, and
Betul Hatipoglu
January 1991,
Duodecim; laaketieteellinen aikakauskirja,
Khawla F Ali, and
Betul Hatipoglu
June 2019,
Science translational medicine,
Khawla F Ali, and
Betul Hatipoglu
August 2009,
Diabetes care,
Khawla F Ali, and
Betul Hatipoglu
January 1987,
Langenbecks Archiv fur Chirurgie,
Khawla F Ali, and
Betul Hatipoglu
November 1976,
Comprehensive therapy,
Khawla F Ali, and
Betul Hatipoglu
March 2013,
Annals of biomedical engineering,
